Sun Pharma Sees Trading Frenzy as Volumes Surge, Signals Renewed Investor Interest

Sun Pharmaceutical Industries witnessed a sharp spike in trading activity today, with volumes soaring to over 2 million shares-well above its average. The stock traded between ₹1,726.6 and ₹1,765.0, closing at ₹1,729.0 on the NSE, reflecting a marginal dip but maintaining robust liquidity. This surge follows a recent trend reversal after several days of decline, drawing attention from both institutional and retail investors.

 

Options market activity also heated up, with significant interest in call options at strike prices of ₹1,740 and ₹1,760, highlighting bullish sentiment despite broader market volatility. Analysts note that Sun Pharma’s consistent financial performance and its upcoming earnings announcement on May 22 have kept the stock in focus. As India’s largest pharma company, Sun Pharma’s trading momentum underscores its central role in the sector’s market dynamics.

 

Source: Moneycontrol, MarketsMojo